by Advize Admin | Jun 16, 2023 | FWA, Healthcare
For those that remember Solaraze, it is one of the name brands for Diclofenac. Diclofenac is commonly known today as Voltaren. In 2018, the OIG conducted a study that reflected that there were some strong fraud indicators on the off-label use of Diclofenac (under...
by Advize Admin | May 26, 2023 | Coding, FWA
Within the past few weeks, we have seen at least two of the large payors seek to institute policies that would require providers to submit their medical records when an Evaluation and Management (E&M) is appended with Modifier 25. While not having a discussion on...
by Advize Admin | May 5, 2023
OIG Roundtable (Formerly Retro Fraud) Episode 31: Challenges of Managing an SIU Play Episode Pause Episode Mute/Unmute Episode Rewind 10 Seconds 1x Fast Forward 30 seconds 00:00 / 33:20 Subscribe Share Spotify RSS Feed Share Link Embed Download file | Play in new...
by Advize Admin | Mar 10, 2023
OIG Roundtable (Formerly Retro Fraud) Episode 24: Quick Hello from the ABA Health Law Emerging Issues in Healthcare Law Conference Play Episode Pause Episode Mute/Unmute Episode Rewind 10 Seconds 1x Fast Forward 30 seconds 00:00 / 12:44 Subscribe Share Spotify RSS...
by Advize Admin | Mar 3, 2023 | Compliance, Providers
BUTTE, Mont. — Jennifer Mitchell remembered getting a call nearly two years ago that her 69-year-old husband, Bill, had crashed his car and had been committed to the Montana State Hospital, the state-run psychiatric hospital for adults about 20 miles from their home...
Recent Comments